Minimum Residual Disease in Acute Lymphoblastic Leukemia
5 Visninger
• 08/04/23
0
0
Indlejre
administrator
Abonnenter
In this segment, Jeffrey Lancet, MD; Raoul Tibes, MD; and Mark R. Litzow, MD, describe various methodologies in monitoring minimum residual disease in acute lymphoblastic leukemia.
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer